Healthpeak Properties announced it has received approval of entitlements for Phases II and III of its purpose-built lab development campus, Vantage, in South San Francisco. The newly awarded entitlements provide Healthpeak the ability to deliver an additional 1.3 million square feet of lab space, bringing the combined campus to approximately 1.7 million square feet upon full buildout. These entitlements represent double the allowable density compared to when Healthpeak originally acquired the land. The long-term nature of the entitlements offers flexibility to deliver the balance of the development in phases to align with market demand. “Inspired by our success at The Cove and other nearby campuses, the Vantage master plan is a continuation of Healthpeak’s vision to create a world class campus that provides an inviting and collaborative setting for the nurturing of ideas, knowledge, and discoveries that shape the biotech industry,” said Scott Bohn, Healthpeak’s Chief Development Officer and Co-Head of Lab. “The future phases of Vantage provide Healthpeak a strategic development pipeline to meet the growth needs of our current and future tenants.” Mr. Bohn continued, “We’re appreciative of the collaborative and mutually beneficial relationship we have fostered with the City of South San Francisco over the past three decades and look forward to Vantage furthering South San Francisco’s position as a leading market for biotech innovation.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PEAK:
- Healthpeak downgraded to Underperform at BofA after Physicians Realty deal
- Healthpeak downgraded to Underperform from Neutral at BofA
- Healthpeak cuts FY23 AFFO view to $1.73-$1.77 from $1.76-$1.78
- Healthpeak reports Q3 AFFO 45c, consensus 44c
- Physicians Realty Trust, Healthpeak to combine in all-stock merger of equals